News and Trends 19 Feb 2019 Skin Microbiome Biotechs Get Funding Boost Two major skin microbiome companies have received investments this week: the Belgian company S-Biomedic, which is developing a probiotic acne treatment, and the UK biotech SkinBioTherapeutics, which is targeting eczema. A lot of attention goes to the gut microbiome when talking about probiotic disease treatments, but skin bacteria may also have potential, as these […] February 19, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Feb 2019 How New Microbiome Diagnostic Technologies Can Save Lives With the rise of a whole new field of research around the microbiome, what role are new technologies to identify microorganisms playing in the future of healthcare? Traditionally, microbes have been seen solely as a threat. But in the last few years, microbiome research has started to shift this view. Today, we know certain microorganisms […] February 19, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 15 Feb 2019 This Lab-on-a-Chip Can Screen Millions of Bacteria in Parallel Our French biotech of the week, Biomillenia, is developing a lab-on-a-chip that can screen millions of strains of bacteria in a fraction of the time it takes for traditional methods. This technology can identify previously unculturable strains for use in agriculture, animal health, or microbiome-based therapies. Mission: To use lab-on-a-chip technology to culture and screen […] February 15, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 1 Feb 2019 This Biotech Links the Gut Microbiome to Diseases Using Norwegian Poo In Norway’s capital city of Oslo, the biotech Bio-Me can rapidly screen for specific gut bacteria, gathering data from thousands of Norwegian stool samples to link the gut microbiome to diseases. Mission: To rapidly screen thousands of stool samples from a Norwegian population study and link the gut microbiome with disease. Client companies will then […] February 1, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 23 Jan 2019 Tackling the Complexity of the Gut Microbiome for Better Treatments An imbalance in gut microbe species is linked with gastrointestinal disease. Philip talked with the CEO and co-founder of the Swiss startup PharmaBiome, Tomas de Wouters, about the complexity of rebalancing the gut microbiome in these conditions. The microbiome is a hugely complex ecosystem of microbes living all around the body. Different parts of the […] January 23, 2019 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 22 Jan 2019 No Guts, No Glory: How Microbiome Research is Changing Medicine Scientists are uncovering many ways that the microorganisms that share our body can influence our health. It appears as though the human microbiome could be the key to treating all sorts of diseases, but how can we make these tiny creatures collaborate with us? Let’s do a gut check. We’ve all been told that our […] January 22, 2019 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Dec 2018 Gut Bacteria Could Combat Obesity and Depression A five-year microbiome project, funded by the EU, has linked the presence of specific strains of gut bacteria to protection from obesity, glucose intolerance, and even depression. The project, called MyNewGut, found evidence that specific strains of bacteria can contribute to obesity in people on high-fat or high-sugar diets. Research led by Yolanda Sanz, Professor […] December 18, 2018 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Dec 2018 Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease The Israeli biotech BiomX has teamed up with Janssen to use its microbiome technology in the treatment of inflammatory bowel diseases such as Crohn’s disease. Janssen aims to use BiomX’s technology to predict which patients with inflammatory bowel diseases will respond best its treatments based on their microbiome. The financial details of the collaboration were […] December 13, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2018 Microbiome Therapy Shows Early Promise in Cancer Patients A clinical trial run by MaaT Pharma has shown that restoring the microbiome of patients undergoing chemotherapy has potential to improve the outcome of patients with the blood cancer acute myeloid leukemia (AML). The microbes living in our gut can have a big influence on the success of cancer treatments. Some microorganisms are known to […] December 4, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 21 Nov 2018 5 Challenges to Unlocking the Real Potential of the Human Microbiome The study of the human microbiome — the microorganisms living in our body — is a very young field of research that is making big promises to treat all sorts of human diseases. As we get close to the approval of the first treatment based on microbiome science, it’s important to be aware of the […] November 21, 2018 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2018 Gut Bacteria Treatment Shows Promise for Rare Genetic Kidney Condition The Swedish biotech Oxthera reported positive preliminary Phase II results using its gut bacteria treatment, Oxabact, in patients with a rare genetic condition that causes kidney failure. The results came from an interim analysis one year into a three-year trial, where Oxthera is testing its gut microbiome treatment on patients with primary hyperoxaluria type […] November 2, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2018 UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy UK-based Microbiotica has received a £4M investment from Seventure’s fund dedicated to investments in the microbiome space. With Seventure coming on board as a new investor, Microbiotica has now raised a total of £12M since its foundation in 2016. The company, a spin-out of the Sanger Institute in Cambridge, seeks to find and exploit precise […] October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email